Anti-Cav1.2 Ca2+ Channel Recombinant Chicken Chimeric mAb (N500/4)
Our chicken Anti-Cav1.2 Ca2+ Channel recombinant monoclonal antibody is a chimeric antibody derived from NeuroMab clone N500/4. It detects human, mouse, and rat Cav1.2 Ca2+ Channel and is purified by affinity chromatography. It works in ELISA, ICC, IHC, WB.
Immunohistochemistry for detection of Cav1.2 calcium channel in adult rat hippocampus using Aves Labs’ anti-Cav1.2 recombinant chicken monoclonal antibody [N500/4] (Cat No. 78-535). Tissue was fixed with 4% paraformaldehyde and paraffin embedded. Heat induced antigen retrieval was performed using citrate buffer (Cat No. AR-6544) and then blocked with Immuno Protein Blocking Solution with Goat Serum (Cat No. AR-6591). The anti-Cav1.2 antibody (Cat No. 78-535) was incubated with the sample at a dilution of 1:250 at 4C overnight. After washing with PBST, the sections were stained using goat anti-chicken IgY CF488 secondary antibody (Cat No. 80-1001-488) (green). DAPI nuclear stain (blue) shows cell nuclei.
Click on image to zoom
Human, Mouse, Rat
ELISA, ICC, IHC, WB
Chicken
SKU: 78-535
Ships: 1-2 business days
Product Details
Cav1.2 Ca2+ Channel
Cav1.2 is the pore-forming subunit of the L-type voltage-gated calcium channel (VGCC). The necessity of calcium for heart contraction was identified in the 1880s, it wasn't until the late 1980s that the CACNA1C gene encoding Cav1.2 was successfully cloned and characterized. Cav1.2 is a "molecular transducer" that converts electrical signals into chemical actions. It is most prominent in cardiac and smooth muscle, as well as in neurons. When the cell membrane depolarizes, Cav1.2 undergoes a conformational change to allow Ca2+ ions to flow into the cytoplasm. In the heart, this influx is the first step for excitation-contraction coupling, as it triggers the RyR2 receptors to release the bulk of the calcium needed for a heartbeat. In the brain, Cav1.2-mediated calcium entry is vital for Long-Term Potentiation (LTP) and gene expression. Dysfunction in Cav1.2 is clinically linked to Timothy Syndrome, a severe multisystem disorder characterized by cardiac arrhythmias and autism.
Purified by affinity chromatography
1 mg/mL
Recombinant
N500/4
IgY
ELISA, ICC, IHC, WB
Chicken
Cacna1c
240 kDa
Unconjugated
Recombinant protein amino acids 785-900 (ID I-II cytoplasmic loop) of mouse Cav1.2 (also known as voltage-dependent L-type calcium channel subunit alpha-1C, Cacna1c, accession number Q01815) produced recombinantly in E. Coli.
Mouse
Human, Mouse, Rat
Aliquot and store at ≤ -20°C for long term storage. For short term storage, store at 2-8°C. For maximum recovery of product, centrifuge the vial prior to removing the cap.
Liquid
This recombinant antibody is a chimeric antibody created by replacing the mouse heavy and light constant regions of clone N500/4 with chicken IgY heavy and light constant regions. As such this antibody retains the same binding performance as the original clone N500/4 but can be detected using standard anti-chicken secondary antibodies allowing flexibility for multiplexing applications. This antibody is expressed recombinantly in mammalian cells and then affinity purified from the cell culture media.
1X PBS, 0.05% Sodium Azide pH 7.4
WB: 1:500-1:1000
WB Brain: 1:500-1:1000
IHC: 1:100-1:500
ICC: 1:100-1:500
WB Brain: 1:500-1:1000
IHC: 1:100-1:500
ICC: 1:100-1:500
Unconjugated
No cross-reactivity reported
Each new lot of antibody is quality control tested by Western blot on rat brain membrane fraction and confirmed to stain the expected molecular weight band.
These antibodies are to be used as research laboratory reagents and are not for use as diagnostic or therapeutic reagents in humans.
United States
24 months from date of receipt
voltage-dependent L-type calcium channel subunit alpha-1C, Cacna1c
Shipped on ice packs

